English

SERACARE LIFE SCIENCES INC

EDGAR

Quarterly report (10-Q) · filed 2012-02-10

38 filing records in this dataset, filed from 2001-10-15 to 2012-02-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

11.4 million USD

2012 Q1 · USD

Exact inputs and evidence

Revenue: 11367823 USD Source

Operating margin

9.29%

2012 Q1 · %

Exact inputs and evidence

Operating Income: 1055700 USD Source
Revenue: 11367823 USD Source

Operating cash flow

1.09 million USD

2012 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 1092437 USD Source

Free cash flow

950 thousand USD

2012 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 1092437 USD Source
Capital Expenditure: 142660 USD Source

Cash and cash equivalents: 19.5 million USD 2011-12-31 Source
Exact value

19488126 USD
Long-term debt including current maturities: Not available
Shares outstanding: 19.4 million shares 2011-12-31 Source
Exact value

19376224 shares

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

44.4 million USD

2011-01-01 – 2011-12-31

Exact inputs and evidence

Revenue: 11002884 USD · 2011-01-01 – 2011-03-31 Source
Revenue: 11028622 USD · 2011-04-01 – 2011-06-30 Source
Revenue: 43484232 USD · 2010-10-01 – 2011-09-30 Source
Revenue: 32494003 USD · 2010-10-01 – 2011-06-30 Source
Revenue: 11367823 USD · 2011-10-01 – 2011-12-31 Source

Net income

2.1 million USD

2011-01-01 – 2011-12-31

Exact inputs and evidence

Net income: 1393833 USD · 2011-01-01 – 2011-03-31 Source
Net income: 523291 USD · 2011-04-01 – 2011-06-30 Source
Net income: 2667006 USD · 2010-10-01 – 2011-09-30 Source
Net income: 3497664 USD · 2010-10-01 – 2011-06-30 Source
Net income: 1011290 USD · 2011-10-01 – 2011-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-02-10.

Financial data available through: 2011-09-30.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2011-09-30
Operating income: 10 of 11 periods available· newest 2011-09-30
Net income: 10 of 11 periods available· newest 2011-09-30
Operating cash flow: 10 of 11 periods available· newest 2011-09-30
Capital expenditure: 10 of 11 periods available· newest 2011-09-30
Total assets: 9 of 11 periods available· newest 2011-09-30
Total liabilities: 8 of 11 periods available· newest 2011-09-30
Current assets: 9 of 11 periods available· newest 2011-09-30
Current liabilities: 9 of 11 periods available· newest 2011-09-30
Cash and cash equivalents: 10 of 11 periods available· newest 2011-09-30
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2011-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-13.7%

Prior period

USD 50.38 million

2009-10-01 – 2010-09-30
Current period

USD 43.48 million

2010-10-01 – 2011-09-30

Exact inputs and evidence

43484232 − 50380140 = -6895908 USD

50380140 USD · 2009-10-01 – 2010-09-30
Inspect prior input Prior source
43484232 USD · 2010-10-01 – 2011-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SERACARE LIFE SCIENCES INC · 2011-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Year-over-year change in Revenue: -6895908 USD Concept: fundies:Revenue Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 43484232 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#28623 Filing: 000114420411066031 Input fundies:Revenue: 50380140 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#28499 Filing: 000114420411066031
The citation records this snapshot. The page link may show a newer release later.
Net income
-60.2%

Prior period

USD 6.7 million

2009-10-01 – 2010-09-30
Current period

USD 2.67 million

2010-10-01 – 2011-09-30

Exact inputs and evidence

2667006 − 6704751 = -4037745 USD

6704751 USD · 2009-10-01 – 2010-09-30
Inspect prior input Prior source
2667006 USD · 2010-10-01 – 2011-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SERACARE LIFE SCIENCES INC · 2011-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Year-over-year change in Net income: -4037745 USD Concept: fundies:NetIncome Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 2667006 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#36214 Filing: 000114420411066031 Input fundies:NetIncome: 6704751 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#35589 Filing: 000114420411066031
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-64.6%

Prior period

USD 10.43 million

2009-10-01 – 2010-09-30
Current period

USD 3.7 million

2010-10-01 – 2011-09-30

Exact inputs and evidence

3695857 − 10430526 = -6734669 USD

10430526 USD · 2009-10-01 – 2010-09-30
Inspect prior input Prior source
3695857 USD · 2010-10-01 – 2011-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SERACARE LIFE SCIENCES INC · 2011-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Year-over-year change in Operating cash flow: -6734669 USD Concept: fundies:OperatingCashFlow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 3695857 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58743 Filing: 000114420411066031 Input fundies:OperatingCashFlow: 10430526 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58565 Filing: 000114420411066031
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+290.8%

Prior period

USD 413,823

2009-10-01 – 2010-09-30
Current period

USD 1.62 million

2010-10-01 – 2011-09-30

Exact inputs and evidence

1617359 − 413823 = 1203536 USD

413823 USD · 2009-10-01 – 2010-09-30
Inspect prior input Prior source
1617359 USD · 2010-10-01 – 2011-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SERACARE LIFE SCIENCES INC · 2011-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Year-over-year change in Capital expenditure: 1203536 USD Concept: fundies:CapitalExpenditure Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1617359 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#59272 Filing: 000114420411066031 Input fundies:CapitalExpenditure: 413823 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#59096 Filing: 000114420411066031
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2010-10-01 – 2011-09-30

Revenue USD 43.48 million 100% of revenue
Operating costs Derived USD 40.89 million 94% of revenue
Operating income USD 2.59 million 6% of revenue
Tax, interest and other Derived −USD 77,751 −0.2% of revenue
Net income USD 2.67 million 6.1% of revenue

Cash

Operating cash flow USD 3.7 million 8.5% of revenue
Capital expenditure USD 1.62 million 3.7% of revenue
Free cash flow Derived USD 2.08 million 4.8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Net income was higher than operating income, so the split is not drawn.
2003 11%88%
2004 15%80%
2005 Operating loss: operating costs were 126% of revenue.
2006 Operating loss: operating costs were 113% of revenue.
2007 Operating loss: operating costs were 126% of revenue.
2008 Operating loss: operating costs were 125% of revenue.
2009 Operating loss: operating costs were 134% of revenue.
2010 13%86%
2011 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2001-10-01 – 2002-09-30	25307501	21827353 Derived	3480148	-144686 Derived	3624834	2611849 Derived	Source 2001-10-01 – 2002-09-30: 25307501 USD Inspect Revenue Open source 2001-10-01 – 2002-09-30: 3480148 USD Inspect Operating Income Open source 2001-10-01 – 2002-09-30: 3624834 USD Inspect Net Income Open source 2001-10-01 – 2002-09-30: 2995405 USD Inspect Operating Cash Flow Open source 2001-10-01 – 2002-09-30: 383556 USD Inspect Capital Expenditure Open source
2003 2002-10-01 – 2003-09-30	23202760	20308462 Derived	2894298	278044 Derived	2616254	-846833 Derived	Source 2002-10-01 – 2003-09-30: 23202760 USD Inspect Revenue Open source 2002-10-01 – 2003-09-30: 2894298 USD Inspect Operating Income Open source 2002-10-01 – 2003-09-30: 2616254 USD Inspect Net Income Open source 2002-10-01 – 2003-09-30: -453767 USD Inspect Operating Cash Flow Open source 2002-10-01 – 2003-09-30: 393066 USD Inspect Capital Expenditure Open source
2004 2003-10-01 – 2004-09-30	28441448	22798398 Derived	5643050	1487902 Derived	4155148	-571352 Derived	Source 2003-10-01 – 2004-09-30: 28441448 USD Inspect Revenue Open source 2003-10-01 – 2004-09-30: 5643050 USD Inspect Operating Income Open source 2003-10-01 – 2004-09-30: 4155148 USD Inspect Net Income Open source 2003-10-01 – 2004-09-30: -429333 USD Inspect Operating Cash Flow Open source 2003-10-01 – 2004-09-30: 142019 USD Inspect Capital Expenditure Open source
2005 2004-10-01 – 2005-09-30	50299665	63151305 Derived	-12851640	8245268 Derived	-21096908	-3601878 Derived	Source 2004-10-01 – 2005-09-30: 50299665 USD Inspect Revenue Open source 2004-10-01 – 2005-09-30: -12851640 USD Inspect Operating Income Open source 2004-10-01 – 2005-09-30: -21096908 USD Inspect Net Income Open source 2004-10-01 – 2005-09-30: -2198353 USD Inspect Operating Cash Flow Open source 2004-10-01 – 2005-09-30: 1403525 USD Inspect Capital Expenditure Open source
2006 2005-10-01 – 2006-09-30	49175857	55763726 Derived	-6587869	17690033 Derived	-24277902	-7158083 Derived	Source 2005-10-01 – 2006-09-30: 49175857 USD Inspect Revenue Open source 2005-10-01 – 2006-09-30: -6587869 USD Inspect Operating Income Open source 2005-10-01 – 2006-09-30: -24277902 USD Inspect Net Income Open source 2005-10-01 – 2006-09-30: -6170224 USD Inspect Operating Cash Flow Open source 2005-10-01 – 2006-09-30: 987859 USD Inspect Capital Expenditure Open source
2007 2006-10-01 – 2007-09-30	47303595	59466480 Derived	-12162885	1001996 Derived	-13164881	-11146634 Derived	Source 2006-10-01 – 2007-09-30: 47303595 USD Inspect Revenue Open source 2006-10-01 – 2007-09-30: -12162885 USD Inspect Operating Income Open source 2006-10-01 – 2007-09-30: -13164881 USD Inspect Net Income Open source 2006-10-01 – 2007-09-30: -10654633 USD Inspect Operating Cash Flow Open source 2006-10-01 – 2007-09-30: 492001 USD Inspect Capital Expenditure Open source
2008 2007-10-01 – 2008-09-30	48966648	61140212 Derived	-12173564	-210515 Derived	-11963049	-7584117 Derived	Source 2007-10-01 – 2008-09-30: 48966648 USD Inspect Revenue Open source 2007-10-01 – 2008-09-30: -12173564 USD Inspect Operating Income Open source 2007-10-01 – 2008-09-30: -11963049 USD Inspect Net Income Open source 2007-10-01 – 2008-09-30: -2614509 USD Inspect Operating Cash Flow Open source 2007-10-01 – 2008-09-30: 4969608 USD Inspect Capital Expenditure Open source
2009 2008-10-01 – 2009-09-30	44434171	59567059 Derived	-15132888	246307 Derived	-15379195	3240372 Derived	Source 2008-10-01 – 2009-09-30: 44434171 USD Inspect Revenue Open source 2008-10-01 – 2009-09-30: -15132888 USD Inspect Operating Income Open source 2008-10-01 – 2009-09-30: -15379195 USD Inspect Net Income Open source 2008-10-01 – 2009-09-30: 3961531 USD Inspect Operating Cash Flow Open source 2008-10-01 – 2009-09-30: 721159 USD Inspect Capital Expenditure Open source
2010 2009-10-01 – 2010-09-30	50380140	43532237 Derived	6847903	143152 Derived	6704751	10016703 Derived	Source 2009-10-01 – 2010-09-30: 50380140 USD Inspect Revenue Open source 2009-10-01 – 2010-09-30: 6847903 USD Inspect Operating Income Open source 2009-10-01 – 2010-09-30: 6704751 USD Inspect Net Income Open source 2009-10-01 – 2010-09-30: 10430526 USD Inspect Operating Cash Flow Open source 2009-10-01 – 2010-09-30: 413823 USD Inspect Capital Expenditure Open source
2011 2010-10-01 – 2011-09-30	43484232	40894977 Derived	2589255	-77751 Derived	2667006	2078498 Derived	Source 2010-10-01 – 2011-09-30: 43484232 USD Inspect Revenue Open source 2010-10-01 – 2011-09-30: 2589255 USD Inspect Operating Income Open source 2010-10-01 – 2011-09-30: 2667006 USD Inspect Net Income Open source 2010-10-01 – 2011-09-30: 3695857 USD Inspect Operating Cash Flow Open source 2010-10-01 – 2011-09-30: 1617359 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 43.5M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-09-30	Revenue	25307501	Revenue: 25307501 Open source
20032003-09-30	Revenue	23202760	Revenue: 23202760 Open source
20042004-09-30	Revenue	28441448	Revenue: 28441448 Open source
20052005-09-30	Revenue	50299665	Revenue: 50299665 Open source
20062006-09-30	Revenue	49175857	Revenue: 49175857 Open source
20072007-09-30	Revenue	47303595	Revenue: 47303595 Open source
20082008-09-30	Revenue	48966648	Revenue: 48966648 Open source
20092009-09-30	Revenue	44434171	Revenue: 44434171 Open source
20102010-09-30	Revenue	50380140	Revenue: 50380140 Open source
20112011-09-30	Revenue	43484232	Revenue: 43484232 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-13.7% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Year over year	No prior comparable period	Revenue: 25307501 Open source
20032003-09-30	Year over year	-8.3%	Revenue: 23202760 Open source Revenue: 25307501 Open source
20042004-09-30	Year over year	22.6%	Revenue: 28441448 Open source Revenue: 23202760 Open source
20052005-09-30	Year over year	76.9%	Revenue: 50299665 Open source Revenue: 28441448 Open source
20062006-09-30	Year over year	-2.2%	Revenue: 49175857 Open source Revenue: 50299665 Open source
20072007-09-30	Year over year	-3.8%	Revenue: 47303595 Open source Revenue: 49175857 Open source
20082008-09-30	Year over year	3.5%	Revenue: 48966648 Open source Revenue: 47303595 Open source
20092009-09-30	Year over year	-9.3%	Revenue: 44434171 Open source Revenue: 48966648 Open source
20102010-09-30	Year over year	13.4%	Revenue: 50380140 Open source Revenue: 44434171 Open source
20112011-09-30	Year over year	-13.7%	Revenue: 43484232 Open source Revenue: 50380140 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 6% 2011

Net margin 6.1% 2011

Free cash flow margin 4.8% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Operating margin	13.8%	Operating Income: 3480148 Open source Revenue: 25307501 Open source
20032003-09-30	Operating margin	12.5%	Operating Income: 2894298 Open source Revenue: 23202760 Open source
20042004-09-30	Operating margin	19.8%	Operating Income: 5643050 Open source Revenue: 28441448 Open source
20052005-09-30	Operating margin	-25.6%	Operating Income: -12851640 Open source Revenue: 50299665 Open source
20062006-09-30	Operating margin	-13.4%	Operating Income: -6587869 Open source Revenue: 49175857 Open source
20072007-09-30	Operating margin	-25.7%	Operating Income: -12162885 Open source Revenue: 47303595 Open source
20082008-09-30	Operating margin	-24.9%	Operating Income: -12173564 Open source Revenue: 48966648 Open source
20092009-09-30	Operating margin	-34.1%	Operating Income: -15132888 Open source Revenue: 44434171 Open source
20102010-09-30	Operating margin	13.6%	Operating Income: 6847903 Open source Revenue: 50380140 Open source
20112011-09-30	Operating margin	6%	Operating Income: 2589255 Open source Revenue: 43484232 Open source
20022002-09-30	Net margin	14.3%	Net Income: 3624834 Open source Revenue: 25307501 Open source
20032003-09-30	Net margin	11.3%	Net Income: 2616254 Open source Revenue: 23202760 Open source
20042004-09-30	Net margin	14.6%	Net Income: 4155148 Open source Revenue: 28441448 Open source
20052005-09-30	Net margin	-41.9%	Net Income: -21096908 Open source Revenue: 50299665 Open source
20062006-09-30	Net margin	-49.4%	Net Income: -24277902 Open source Revenue: 49175857 Open source
20072007-09-30	Net margin	-27.8%	Net Income: -13164881 Open source Revenue: 47303595 Open source
20082008-09-30	Net margin	-24.4%	Net Income: -11963049 Open source Revenue: 48966648 Open source
20092009-09-30	Net margin	-34.6%	Net Income: -15379195 Open source Revenue: 44434171 Open source
20102010-09-30	Net margin	13.3%	Net Income: 6704751 Open source Revenue: 50380140 Open source
20112011-09-30	Net margin	6.1%	Net Income: 2667006 Open source Revenue: 43484232 Open source
20022002-09-30	Free cash flow margin	10.3%	Revenue: 25307501 Open source Operating Cash Flow: 2995405 Open source Capital Expenditure: 383556 Open source
20032003-09-30	Free cash flow margin	-3.6%	Revenue: 23202760 Open source Operating Cash Flow: -453767 Open source Capital Expenditure: 393066 Open source
20042004-09-30	Free cash flow margin	-2%	Revenue: 28441448 Open source Operating Cash Flow: -429333 Open source Capital Expenditure: 142019 Open source
20052005-09-30	Free cash flow margin	-7.2%	Revenue: 50299665 Open source Operating Cash Flow: -2198353 Open source Capital Expenditure: 1403525 Open source
20062006-09-30	Free cash flow margin	-14.6%	Revenue: 49175857 Open source Operating Cash Flow: -6170224 Open source Capital Expenditure: 987859 Open source
20072007-09-30	Free cash flow margin	-23.6%	Revenue: 47303595 Open source Operating Cash Flow: -10654633 Open source Capital Expenditure: 492001 Open source
20082008-09-30	Free cash flow margin	-15.5%	Revenue: 48966648 Open source Operating Cash Flow: -2614509 Open source Capital Expenditure: 4969608 Open source
20092009-09-30	Free cash flow margin	7.3%	Revenue: 44434171 Open source Operating Cash Flow: 3961531 Open source Capital Expenditure: 721159 Open source
20102010-09-30	Free cash flow margin	19.9%	Revenue: 50380140 Open source Operating Cash Flow: 10430526 Open source Capital Expenditure: 413823 Open source
20112011-09-30	Free cash flow margin	4.8%	Revenue: 43484232 Open source Operating Cash Flow: 3695857 Open source Capital Expenditure: 1617359 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 3.7M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-09-30	Operating cash flow	2995405	Operating Cash Flow: 2995405 Open source
20032003-09-30	Operating cash flow	-453767	Operating Cash Flow: -453767 Open source
20042004-09-30	Operating cash flow	-429333	Operating Cash Flow: -429333 Open source
20052005-09-30	Operating cash flow	-2198353	Operating Cash Flow: -2198353 Open source
20062006-09-30	Operating cash flow	-6170224	Operating Cash Flow: -6170224 Open source
20072007-09-30	Operating cash flow	-10654633	Operating Cash Flow: -10654633 Open source
20082008-09-30	Operating cash flow	-2614509	Operating Cash Flow: -2614509 Open source
20092009-09-30	Operating cash flow	3961531	Operating Cash Flow: 3961531 Open source
20102010-09-30	Operating cash flow	10430526	Operating Cash Flow: 10430526 Open source
20112011-09-30	Operating cash flow	3695857	Operating Cash Flow: 3695857 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 2.1M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-09-30	Free cash flow	2611849	Operating Cash Flow: 2995405 Open source Capital Expenditure: 383556 Open source
20032003-09-30	Free cash flow	-846833	Operating Cash Flow: -453767 Open source Capital Expenditure: 393066 Open source
20042004-09-30	Free cash flow	-571352	Operating Cash Flow: -429333 Open source Capital Expenditure: 142019 Open source
20052005-09-30	Free cash flow	-3601878	Operating Cash Flow: -2198353 Open source Capital Expenditure: 1403525 Open source
20062006-09-30	Free cash flow	-7158083	Operating Cash Flow: -6170224 Open source Capital Expenditure: 987859 Open source
20072007-09-30	Free cash flow	-11146634	Operating Cash Flow: -10654633 Open source Capital Expenditure: 492001 Open source
20082008-09-30	Free cash flow	-7584117	Operating Cash Flow: -2614509 Open source Capital Expenditure: 4969608 Open source
20092009-09-30	Free cash flow	3240372	Operating Cash Flow: 3961531 Open source Capital Expenditure: 721159 Open source
20102010-09-30	Free cash flow	10016703	Operating Cash Flow: 10430526 Open source Capital Expenditure: 413823 Open source
20112011-09-30	Free cash flow	2078498	Operating Cash Flow: 3695857 Open source Capital Expenditure: 1617359 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

14.4% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2002-09-30	Liabilities / assets	Not reported	Total Assets: 19989959 Open source
20032003-09-30	Liabilities / assets	26.7%	Total Liabilities: 7428566 Open source Total Assets: 27851847 Open source
20042004-09-30	Liabilities / assets	48.7%	Total Liabilities: 43364325 Open source Total Assets: 89128046 Open source
2005-09-30	Liabilities / assets	Not reported	No source recorded
20062006-09-30	Liabilities / assets	41.5%	Total Liabilities: 29542282 Open source Total Assets: 71108297 Open source
20072007-09-30	Liabilities / assets	13.5%	Total Liabilities: 7915251 Open source Total Assets: 58439745 Open source
20082008-09-30	Liabilities / assets	20.9%	Total Liabilities: 10686330 Open source Total Assets: 51096555 Open source
20092009-09-30	Liabilities / assets	24%	Total Liabilities: 8270183 Open source Total Assets: 34464121 Open source
20102010-09-30	Liabilities / assets	20.9%	Total Liabilities: 9123907 Open source Total Assets: 43625502 Open source
20112011-09-30	Liabilities / assets	14.4%	Total Liabilities: 6473827 Open source Total Assets: 45078202 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

7.82× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Current assets / current liabilities	5.76×	Current Assets: 15619465 Open source Current Liabilities: 2713121 Open source
20032003-09-30	Current assets / current liabilities	2.66×	Current Assets: 19736413 Open source Current Liabilities: 7428566 Open source
20042004-09-30	Current assets / current liabilities	2.41×	Current Assets: 40932047 Open source Current Liabilities: 17009169 Open source
2005-09-30	Current assets / current liabilities	Not reported	No source recorded
20062006-09-30	Current assets / current liabilities	1.33×	Current Assets: 31283731 Open source Current Liabilities: 23506863 Open source
20072007-09-30	Current assets / current liabilities	4.71×	Current Assets: 25490758 Open source Current Liabilities: 5406339 Open source
20082008-09-30	Current assets / current liabilities	2.69×	Current Assets: 22793079 Open source Current Liabilities: 8463169 Open source
20092009-09-30	Current assets / current liabilities	4.66×	Current Assets: 22469217 Open source Current Liabilities: 4825254 Open source
20102010-09-30	Current assets / current liabilities	4.77×	Current Assets: 32843534 Open source Current Liabilities: 6885021 Open source
20112011-09-30	Current assets / current liabilities	7.82×	Current Assets: 34740072 Open source Current Liabilities: 4442884 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2001-10-01 – 2002-09-30	USD 3.62 million Exact value Exact value: 3624834 USD 2001-10-01 – 2002-09-30: 3624834 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2002-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: 3624834 USD Concept: fundies:NetIncome Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:NetIncome: 3624834 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5010 The citation records this snapshot. The page link may show a newer release later.	USD 3 million Exact value Exact value: 2995405 USD 2001-10-01 – 2002-09-30: 2995405 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2002-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: 2995405 USD Concept: fundies:OperatingCashFlow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2995405 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5220 The citation records this snapshot. The page link may show a newer release later.	USD 383,556 Exact value Exact value: 383556 USD 2001-10-01 – 2002-09-30: 383556 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2002-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 383556 USD Concept: fundies:CapitalExpenditure Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 383556 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5262 The citation records this snapshot. The page link may show a newer release later.	USD 2.61 million Calculation and evidence 2995405 − 383556 USD Exact free cash flow: 2611849 USD 2001-10-01 – 2002-09-30: 2995405 USD · Inspect Operating Cash Flow · Source 2001-10-01 – 2002-09-30: 383556 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2002-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: 2611849 USD Concept: free-cash-flow Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2995405 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5220 Input fundies:CapitalExpenditure: 383556 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5262 The citation records this snapshot. The page link may show a newer release later.
2003 2002-10-01 – 2003-09-30	USD 2.62 million Exact value Exact value: 2616254 USD 2002-10-01 – 2003-09-30: 2616254 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2003-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: 2616254 USD Concept: fundies:NetIncome Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:NetIncome: 2616254 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5010 The citation records this snapshot. The page link may show a newer release later.	−USD 453,767 Exact value Exact value: -453767 USD 2002-10-01 – 2003-09-30: -453767 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2003-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: -453767 USD Concept: fundies:OperatingCashFlow Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -453767 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5220 The citation records this snapshot. The page link may show a newer release later.	USD 393,066 Exact value Exact value: 393066 USD 2002-10-01 – 2003-09-30: 393066 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2003-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 393066 USD Concept: fundies:CapitalExpenditure Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 393066 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5262 The citation records this snapshot. The page link may show a newer release later.	−USD 846,833 Calculation and evidence -453767 − 393066 USD Exact free cash flow: -846833 USD 2002-10-01 – 2003-09-30: -453767 USD · Inspect Operating Cash Flow · Source 2002-10-01 – 2003-09-30: 393066 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2003-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: -846833 USD Concept: free-cash-flow Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -453767 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5220 Input fundies:CapitalExpenditure: 393066 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5262 The citation records this snapshot. The page link may show a newer release later.
2004 2003-10-01 – 2004-09-30	USD 4.16 million Exact value Exact value: 4155148 USD 2003-10-01 – 2004-09-30: 4155148 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2004-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: 4155148 USD Concept: fundies:NetIncome Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:NetIncome: 4155148 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5010 The citation records this snapshot. The page link may show a newer release later.	−USD 429,333 Exact value Exact value: -429333 USD 2003-10-01 – 2004-09-30: -429333 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2004-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: -429333 USD Concept: fundies:OperatingCashFlow Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -429333 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5220 The citation records this snapshot. The page link may show a newer release later.	USD 142,019 Exact value Exact value: 142019 USD 2003-10-01 – 2004-09-30: 142019 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2004-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 142019 USD Concept: fundies:CapitalExpenditure Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 142019 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5262 The citation records this snapshot. The page link may show a newer release later.	−USD 571,352 Calculation and evidence -429333 − 142019 USD Exact free cash flow: -571352 USD 2003-10-01 – 2004-09-30: -429333 USD · Inspect Operating Cash Flow · Source 2003-10-01 – 2004-09-30: 142019 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2004-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: -571352 USD Concept: free-cash-flow Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -429333 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5220 Input fundies:CapitalExpenditure: 142019 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001193125-04-212900.txt#5262 The citation records this snapshot. The page link may show a newer release later.
2005 2004-10-01 – 2005-09-30	−USD 21.1 million Exact value Exact value: -21096908 USD 2004-10-01 – 2005-09-30: -21096908 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2005-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: -21096908 USD Concept: fundies:NetIncome Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2005-09-30&surface=latest&period_type=duration&start=2004-10-01&unit=USD&dimensions= Input fundies:NetIncome: -21096908 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-000433.txt#30260 The citation records this snapshot. The page link may show a newer release later.	−USD 2.2 million Exact value Exact value: -2198353 USD 2004-10-01 – 2005-09-30: -2198353 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2005-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: -2198353 USD Concept: fundies:OperatingCashFlow Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2005-09-30&surface=latest&period_type=duration&start=2004-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2198353 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-000433.txt#31294 The citation records this snapshot. The page link may show a newer release later.	USD 1.4 million Exact value Exact value: 1403525 USD 2004-10-01 – 2005-09-30: 1403525 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2005-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 1403525 USD Concept: fundies:CapitalExpenditure Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2005-09-30&surface=latest&period_type=duration&start=2004-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1403525 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-000433.txt#31421 The citation records this snapshot. The page link may show a newer release later.	−USD 3.6 million Calculation and evidence -2198353 − 1403525 USD Exact free cash flow: -3601878 USD 2004-10-01 – 2005-09-30: -2198353 USD · Inspect Operating Cash Flow · Source 2004-10-01 – 2005-09-30: 1403525 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2005-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: -3601878 USD Concept: free-cash-flow Period: 2004-10-01 to 2005-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2198353 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-000433.txt#31294 Input fundies:CapitalExpenditure: 1403525 USD (2004-10-01 to 2005-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-000433.txt#31421 The citation records this snapshot. The page link may show a newer release later.
2006 2005-10-01 – 2006-09-30	−USD 24.28 million Exact value Exact value: -24277902 USD 2005-10-01 – 2006-09-30: -24277902 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2006-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: -24277902 USD Concept: fundies:NetIncome Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2006-09-30&surface=latest&period_type=duration&start=2005-10-01&unit=USD&dimensions= Input fundies:NetIncome: -24277902 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-007840.txt#22397 The citation records this snapshot. The page link may show a newer release later.	−USD 6.17 million Exact value Exact value: -6170224 USD 2005-10-01 – 2006-09-30: -6170224 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2006-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: -6170224 USD Concept: fundies:OperatingCashFlow Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2006-09-30&surface=latest&period_type=duration&start=2005-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6170224 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-007840.txt#23345 The citation records this snapshot. The page link may show a newer release later.	USD 987,859 Exact value Exact value: 987859 USD 2005-10-01 – 2006-09-30: 987859 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2006-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 987859 USD Concept: fundies:CapitalExpenditure Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2006-09-30&surface=latest&period_type=duration&start=2005-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 987859 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-007840.txt#23472 The citation records this snapshot. The page link may show a newer release later.	−USD 7.16 million Calculation and evidence -6170224 − 987859 USD Exact free cash flow: -7158083 USD 2005-10-01 – 2006-09-30: -6170224 USD · Inspect Operating Cash Flow · Source 2005-10-01 – 2006-09-30: 987859 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2006-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: -7158083 USD Concept: free-cash-flow Period: 2005-10-01 to 2006-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6170224 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-007840.txt#23345 Input fundies:CapitalExpenditure: 987859 USD (2005-10-01 to 2006-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950135-08-007840.txt#23472 The citation records this snapshot. The page link may show a newer release later.
2007 2006-10-01 – 2007-09-30	−USD 13.16 million Exact value Exact value: -13164881 USD 2006-10-01 – 2007-09-30: -13164881 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2007-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: -13164881 USD Concept: fundies:NetIncome Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2007-09-30&surface=latest&period_type=duration&start=2006-10-01&unit=USD&dimensions= Input fundies:NetIncome: -13164881 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950123-09-064370.txt#23128 The citation records this snapshot. The page link may show a newer release later.	−USD 10.65 million Exact value Exact value: -10654633 USD 2006-10-01 – 2007-09-30: -10654633 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2007-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: -10654633 USD Concept: fundies:OperatingCashFlow Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2007-09-30&surface=latest&period_type=duration&start=2006-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10654633 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950123-09-064370.txt#24119 The citation records this snapshot. The page link may show a newer release later.	USD 492,001 Exact value Exact value: 492001 USD 2006-10-01 – 2007-09-30: 492001 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2007-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 492001 USD Concept: fundies:CapitalExpenditure Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2007-09-30&surface=latest&period_type=duration&start=2006-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 492001 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950123-09-064370.txt#24246 The citation records this snapshot. The page link may show a newer release later.	−USD 11.15 million Calculation and evidence -10654633 − 492001 USD Exact free cash flow: -11146634 USD 2006-10-01 – 2007-09-30: -10654633 USD · Inspect Operating Cash Flow · Source 2006-10-01 – 2007-09-30: 492001 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2007-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: -11146634 USD Concept: free-cash-flow Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10654633 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950123-09-064370.txt#24119 Input fundies:CapitalExpenditure: 492001 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0000950123-09-064370.txt#24246 The citation records this snapshot. The page link may show a newer release later.
2008 2007-10-01 – 2008-09-30	−USD 11.96 million Exact value Exact value: -11963049 USD 2007-10-01 – 2008-09-30: -11963049 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2008-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: -11963049 USD Concept: fundies:NetIncome Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2008-09-30&surface=latest&period_type=duration&start=2007-10-01&unit=USD&dimensions= Input fundies:NetIncome: -11963049 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001144204-10-064198.txt#11765 The citation records this snapshot. The page link may show a newer release later.	−USD 2.61 million Exact value Exact value: -2614509 USD 2007-10-01 – 2008-09-30: -2614509 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2008-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: -2614509 USD Concept: fundies:OperatingCashFlow Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2008-09-30&surface=latest&period_type=duration&start=2007-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2614509 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001144204-10-064198.txt#12395 The citation records this snapshot. The page link may show a newer release later.	USD 4.97 million Exact value Exact value: 4969608 USD 2007-10-01 – 2008-09-30: 4969608 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2008-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 4969608 USD Concept: fundies:CapitalExpenditure Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2008-09-30&surface=latest&period_type=duration&start=2007-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4969608 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001144204-10-064198.txt#12455 The citation records this snapshot. The page link may show a newer release later.	−USD 7.58 million Calculation and evidence -2614509 − 4969608 USD Exact free cash flow: -7584117 USD 2007-10-01 – 2008-09-30: -2614509 USD · Inspect Operating Cash Flow · Source 2007-10-01 – 2008-09-30: 4969608 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2008-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: -7584117 USD Concept: free-cash-flow Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2614509 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001144204-10-064198.txt#12395 Input fundies:CapitalExpenditure: 4969608 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/0001144204-10-064198.txt#12455 The citation records this snapshot. The page link may show a newer release later.
2009 2008-10-01 – 2009-09-30	−USD 15.38 million Exact value Exact value: -15379195 USD 2008-10-01 – 2009-09-30: -15379195 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2009-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: -15379195 USD Concept: fundies:NetIncome Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:NetIncome: -15379195 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#34960 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.	USD 3.96 million Exact value Exact value: 3961531 USD 2008-10-01 – 2009-09-30: 3961531 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2009-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: 3961531 USD Concept: fundies:OperatingCashFlow Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3961531 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58388 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.	USD 721,159 Exact value Exact value: 721159 USD 2008-10-01 – 2009-09-30: 721159 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2009-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 721159 USD Concept: fundies:CapitalExpenditure Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 721159 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58920 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.	USD 3.24 million Calculation and evidence 3961531 − 721159 USD Exact free cash flow: 3240372 USD 2008-10-01 – 2009-09-30: 3961531 USD · Inspect Operating Cash Flow · Source 2008-10-01 – 2009-09-30: 721159 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2009-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: 3240372 USD Concept: free-cash-flow Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3961531 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58388 Filing: 000114420411066031 Input fundies:CapitalExpenditure: 721159 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58920 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.
2010 2009-10-01 – 2010-09-30	USD 6.7 million Exact value Exact value: 6704751 USD 2009-10-01 – 2010-09-30: 6704751 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2010-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: 6704751 USD Concept: fundies:NetIncome Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:NetIncome: 6704751 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#35589 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.	USD 10.43 million Exact value Exact value: 10430526 USD 2009-10-01 – 2010-09-30: 10430526 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2010-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: 10430526 USD Concept: fundies:OperatingCashFlow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10430526 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58565 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.	USD 413,823 Exact value Exact value: 413823 USD 2009-10-01 – 2010-09-30: 413823 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2010-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 413823 USD Concept: fundies:CapitalExpenditure Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 413823 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#59096 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.	USD 10.02 million Calculation and evidence 10430526 − 413823 USD Exact free cash flow: 10016703 USD 2009-10-01 – 2010-09-30: 10430526 USD · Inspect Operating Cash Flow · Source 2009-10-01 – 2010-09-30: 413823 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2010-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: 10016703 USD Concept: free-cash-flow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10430526 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58565 Filing: 000114420411066031 Input fundies:CapitalExpenditure: 413823 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#59096 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.
2011 2010-10-01 – 2011-09-30	USD 2.67 million Exact value Exact value: 2667006 USD 2010-10-01 – 2011-09-30: 2667006 USD Inspect Net Income Open source Share or cite Citation for Net Income · SERACARE LIFE SCIENCES INC · 2011-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Net Income: 2667006 USD Concept: fundies:NetIncome Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ANetIncome&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:NetIncome: 2667006 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#36214 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.	USD 3.7 million Exact value Exact value: 3695857 USD 2010-10-01 – 2011-09-30: 3695857 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SERACARE LIFE SCIENCES INC · 2011-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Operating Cash Flow: 3695857 USD Concept: fundies:OperatingCashFlow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3AOperatingCashFlow&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3695857 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58743 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.	USD 1.62 million Exact value Exact value: 1617359 USD 2010-10-01 – 2011-09-30: 1617359 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SERACARE LIFE SCIENCES INC · 2011-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Capital Expenditure: 1617359 USD Concept: fundies:CapitalExpenditure Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295/explain?concept=fundies%3ACapitalExpenditure&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1617359 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#59272 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.	USD 2.08 million Calculation and evidence 3695857 − 1617359 USD Exact free cash flow: 2078498 USD 2010-10-01 – 2011-09-30: 3695857 USD · Inspect Operating Cash Flow · Source 2010-10-01 – 2011-09-30: 1617359 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SERACARE LIFE SCIENCES INC · 2011-09-30 SERACARE LIFE SCIENCES INC (edgar:1156295) Free cash flow: 2078498 USD Concept: free-cash-flow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T19:14:18Z Snapshot: c0d224fecd6766f24271c7b68bcd5889c5181dd9973c7fb8f93a36eea9d7e3bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1156295?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3695857 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#58743 Filing: 000114420411066031 Input fundies:CapitalExpenditure: 1617359 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1156295/000114420411066031/srls-20110930.xml#59272 Filing: 000114420411066031 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

38 filings · 397 latest values · 397 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001156295, 1156295, edgar:1156295, srls

Also known as SERACARE LIFE SCIENCES INC

SERACARE LIFE SCIENCES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2011 2010-10-01 – 2011-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation